MedPath
NMPA Approval

Doxazosin Mesylate Tablets

国药准字H20050083

January 9, 2020

Drug Information

甲磺酸多沙唑嗪片

东港天乐

瑞易宁

片剂

2mg(按多沙唑嗪计)

化学药品

January 9, 2020

Company Information

Applicant Company

Manufacturing Company

浙江省台州市椒江区滨海路27号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸多沙唑嗪片 - NMPA 批准文号 | MedPath